Low-dose peginterferon alfa-2a (40kd) (Pegasys (R)) to treat hepatitis C-infected, end-stage renal disease patients undergoing haemodialysis: Final study results
43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, Italy, 23 - 27 April 2008, vol.48, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 48
- Doi Number: 10.1016/s0168-8278(08)61001-6
- City: Milan
- Country: Italy
- Istanbul University Affiliated: Yes